Waterfall charts of weight changes from baseline to year one of the study participants (n = 105).

<p>Waterfall charts of weight changes from baseline to year one of the study participants (n = 105).</p

Lifestyle changes and lifestyle goals achieved during follow-up (three-year assessment).

<p>Lifestyle changes and lifestyle goals achieved during follow-up (three-year assessment).</p

Clinical and metabolic characteristic of people who maintained and did not maintain weight loss during follow-up.

<p>Clinical and metabolic characteristic of people who maintained and did not maintain weight loss during follow-up.</p

Unadjusted and adjusted odds ratios of predictors of weight loss maintenance during follow-up in the study participants.

<p>Unadjusted and adjusted odds ratios of predictors of weight loss maintenance during follow-up in the study participants.</p

Lifestyle changes and lifestyle goals achieved after intervention (one year assessment).

<p>Lifestyle changes and lifestyle goals achieved after intervention (one year assessment).</p

Blood glucose level versus time after injection of Lys⁴⁰(Ahx-HYNIC-^99mTc/EDDA)NH₂]-exendin-4—the group of patients with MTC.

<p>Blood glucose level versus time after injection of Lys⁴⁰(Ahx-HYNIC-^99mTc/EDDA)NH₂]-exendin-4—the group of patients with MTC.</p

A 75-years old male with suspicion of insulinoma—^99mTc-GLP1scintigraphy.

<p>^99mTc-GLP1scintigraphy revealed the focus of insulinoma in the pancreas—patient was disqualified from surgical excision of the tumor due to severe heart failure. The study was performed with dual-head, large field of view E.CAM gamma camera with low-energy high resolution (LEHR) collimators and images were evaluated with CT examination imposed by software fusion. A. Fusion of GLP-1 receptor imaging and CT—axial slice, B. CT—axial slice.</p

A 77-year old female—^99mTc-GLP1-SPECT/CT.

<p>^99mTc-GLP1-SPECT/CT (Single Photo Emission Computed Tomography/Computed Tomography) revealed bifocal insulinoma (one focus is well visible on the border of the pancreatic body and tail, T/nT (Target/non-target) ratio 3.4; the second one is smaller, less visible in the pancreatic tail, T/nT ratio 1.7). Lesions were not detected by other diagnostic methods. Histopathology confirmed two foci of insulinoma: 9 mm and 2 mm in diameter. A. GLP-1 receptor imaging—MIP (<i>Maximum Intensity Projection</i>), B. Fusion of GLP-1 receptor imaging and CT—axial slice, C. CT—axial slice.</p

Information about patients and examinations performed.

<p>Information about patients and examinations performed.</p